Benzinga.com5d
Breaking Down BioNTech: 16 Analysts Share Their Views
16 analysts have expressed a variety of opinions on BioNTech BNTX over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...
SWR7d
BioNTech steigert Umsatz mit angepassten Corona-Impfstoffen
Das Mainzer Pharmaunternehmen BioNTech konnte im dritten Quartal seinen Umsatz wieder steigern. Im Zeitraum zwischen Juli und September lag der Umsatz bei rund 1,2 Milliarden Euro. Im ...
Bloomberg L.P.7d
BioNTech Beats Expectations, Gives Update on Cancer Drugs
BioNTech SE reported a surprise profit in the third quarter, helped by solid sales of its variant-adapted Covid-19 vaccines. Mainz, Germany-based BioNTech posted earnings of €0.81 ($0.88 ...
pharmaphorum7d
Moderna and BioNTech – who are they?
Moderna and BioNTech, two rising stars in biotech ... two years after BioNTech began operating from a small lab in Mainz, Germany. But both drew on the mRNA technology developed by Katalin ...
Frankfurter Allgemeine Zeitung7d
Biontech profitiert von angepassten Corona-Impfstoffen
2,4 bis 2,6 Milliarden Euro sollen in diesem Jahr in die Forschung und Entwicklung von Biontech fließen. Gebremst wird in Mainz dagegen bei den Ausgaben für Vertrieb und Verwaltung sowie bei den ...
Business Insider7d
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Conference call and webcast scheduled for November 4, 2024, at 8:00 a.m. EST (2:00 p.m. CET) MAINZ, Germany, November 4, 2024 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the ...
FierceBiotech24d
BioNTech-OncoC4 phase 3 cancer trial under partial hold after varying results reported
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing varying results among patients. The hold impacts an open-label trial ...
Finanzen3d
Wer­bungBioNTech (ADRs)-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
01.11.24 NASDAQ Composite Index-Papier Gilead Sciences-Aktie: So viel Gewinn hätte ein Gilead Sciences-Investment von vor 3 Jahren eingefahren ...
Seeking Alpha23d
BioNTech and Moderna: A tale of two mRNA developers
In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created ...
Nasdaq7d
BioNTech Q3 Net Profit Rises; Backs FY24 Revenue Outlook Range, But At The Low End
(RTTNews) - Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net profit of 198.1 million euros or 0.81 euros per share for the third quarter ...
Business Insider28d
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price target of $145.00. The company’s shares closed last ...